Home page Home page

Levitra
vardenafil

Package Leaflet: Information for the user


Levitra 5 mg film-coated tablets

vardenafil


Read all of this leaflet carefully before you start using this medicine because it contains important information for you.


Warnings and precautions

Talk to your doctor or pharmacist before taking Levitra.


Take special care with Levitra


Children and adolescents

Levitra is not intended for use by children or adolescents under 18.


Other medicines and Levitra

Please tell your doctor or pharmacist if you are using, have recently used or might use any other medicines, including medicines obtained without a prescription.

Some medicines may cause problems, especially these:


Do not take Levitra film-coated tablets with any other forms of Levitra.


Do not take Levitra more than once a day.


Tell your doctor if you think Levitra is too strong or too weak. He or she may suggest a switch to an alternative Levitra formulation with a different dose, depending on how well it works for you.


If you take more Levitra than you should

Men who take too much Levitra may experience more side effects or may get severe back pain. If you take more Levitra than you should, tell your doctor.


If you have any further questions on the use of this medicine, ask your doctor or pharmacist.


  1. Possible side effects


    Like all medicines, this medicine can cause side effects, although not everybody gets them. Most of the effects are mild or moderate.


    Partial, sudden, temporary or permanent decrease or loss of vision in one or both eyes has been experienced by patients. Stop taking Levitra and contact your doctor immediately.

    Sudden decrease or loss of hearing has been reported.


    Cases of sudden death, fast or altered heart beat, heart attack, chest pain, and trouble in cerebral circulation (including temporarily decreased blood flow to parts of the brain and bleeding in the brain) have been reported in men taking vardenafil. Most of the men who experienced these side effects had heart problems before taking this medicine. It is not possible to determine whether these events were directly related to vardenafil.


    The chance of having a side effect is described by the following categories:


    Very common:

    may affect more than 1 in 10 users

    • Headache


      Common:

      may affect up to 1 in 10 users

    • Dizziness

    • Flushing

    • Blocked or runny nose

    • Indigestion

      Uncommon:

      may affect up to 1 in 100 users

    • Swelling of skin and mucous tissue including swollen face, lips or throat

    • Sleep disorder

    • Numbness and impaired perception of touch

    • Sleepiness

    • Effects on vision, redness of the eye, effects on colour vision, eye pain and discomfort, light sensitivity

    • Ringing in the ears, vertigo

    • Fast heart beat or pounding heart

    • Breathlessness

    • Stuffy nose

    • Acid reflux, gastritis, abdominal pain, diarrhoea, vomiting, feeling sick (nausea), dry mouth

    • Raised levels of liver enzymes in your blood

    • Rash, reddened skin

    • Back or muscle pain, increase in blood of a muscle enzyme (creatine phosphokinase), muscle stiffness

    • Prolonged erections

    • Malaise


      Rare:

      may affect up to 1 in 1,000 users

    • Inflammation of the eyes (conjunctivitis)

    • Allergic reaction

    • Anxiety

    • Fainting

    • Amnesia

    • Seizure

    • Increased pressure in the eye (glaucoma), lacrimation increased

    • Effects on the heart (such as heart attack, altered heart beat or angina)

    • High or low blood pressure

    • Nose bleed

    • Effect on results of blood tests to check liver function

    • Sensitivity of the skin to sun light

    • Painful erections

    • Chest pain

    • Temporarily decreased blood flow to parts of the brain


      Very rare or not known:

      may affect less than 1 in 10,000 users or frequency cannot be estimated from the available data

    • Blood in the urine (Haematuria)

    • Penile bleeding (Penile Haemorrhage)

    • Presence of blood in the semen (Haematospermia)

    • Sudden death

    • Bleeding in the brain


      Reporting of side effects

      image

      If you get any side effects, talk to your doctor. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.


  2. How to store Levitra


    Keep this medicine out of the sight and reach of children.

    Do not use this medicine after the expiry date which is stated on the carton after “EXP”. The expiry date refers to the last day of that month.


    Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.


  3. Contents of the pack and other information What Levitra contains

Tablet core: crospovidone, magnesium stearate, microcrystalline cellulose, colloidal anhydrous silica.

Film coat: macrogol 400, hypromellose, titanium dioxide (E171), ferric oxide yellow (E172), ferric oxide red (E172).


What Levitra looks like and contents of the pack

Levitra 5 mg film-coated tablets are orange with the BAYER cross on one side and the strength (5) on the other side. The tablets are provided in blister packs containing 2, 4, 8, 12 or 20 tablets. Not all pack sizes may be marketed.


Marketing Authorisation Holder and Manufacturer


Marketing Authorisation Holder Bayer AG

51368 Leverkusen Germany


Manufacturer Bayer AG

Kaiser-Wilhelm-Allee 51368 Leverkusen Germany

For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder.


België/Belgique/Belgien

Bayer SA-NV

Tél/Tel: +32-(0)2-535 63 11

България

Байер България ЕООД

Tел.: +359-(0)2-424 72 80

Česká republika

Bayer s.r.o.

Tel: +420 266 101 111

Danmark

Bayer A/S

Tlf: +45 45 23 50 00

Deutschland

Jenapharm GmbH & Co. KG Tel: +49 (0)3641-87 97 444

Eesti

Bayer OÜ

Tel: +372 655 85 65

Ελλάδα

Bayer Ελλάς ΑΒΕΕ Τηλ: +30 210 61 87 500

España

Bayer Hispania S.L. Tel: +34-93-495 65 00

France

Bayer HealthCare

Tél (N° vert) : +33-(0)800 87 54 54

Hrvatska

Bayer d.o.o.

Tel: + 385-(0)1-6599 900

Ireland

Bayer Limited

Tel: +353 1 216 3300

Ísland

Icepharma hf.

Sími: +354-540 8000

Italia

Bayer S.p.A.

Tel: +39 02 397 81

Κύπρος

NOVAGEM Limited

Τηλ: +357 22 48 38 58

Latvija

SIA Bayer

Tel: +371 67 845 563

Lietuva

UAB Bayer

Tel: +370 523 36 868

Luxembourg/Luxemburg

Bayer SA-NV

Tél/Tel: +32-(0)2-535 63 11

Magyarország Bayer Hungária KFT Tel.: +36 14 87-4100

Malta

Alfred Gera and Sons Ltd. Tel: +35 621 44 62 05

Nederland

Bayer B.V.

Tel: +31-(0)297-28 06 66

Norge

Bayer AS

Tlf: +47-23 13 05 00

Österreich

Bayer Austria Ges. m. b. H. Tel: +43-(0)1-711 46-0

Polska

Bayer Sp. z o.o.

Tel.: +48 22 572 35 00

Portugal

Bayer Portugal, Lda. Tel: +351 21 416 42 00

România

SC Bayer SRL.

Tel: +40-21-529 59 00

Slovenija

Bayer d. o. o.

Tel: +386 (0)1 58 14 400

Slovenská republika

Bayer, spol. s r.o.

Tel: +421 2-59 21 31 11

Suomi/Finland

Bayer Oy

Puh/Tel: +358-20 785 21

Sverige

Bayer AB

Tel: +46 (0)8 580 223 00

United Kingdom (Northern Ireland)

Bayer AG

Tel: +44-(0)118 206 3000


This leaflet was last revised in


.